HIV drug resistance: brief report 2024
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment. In this report, WHO documents
Drugs
-
Advantage BST
EUROPEAN Community (EC) experts are to report shortly whether the bovine somatotropin (BST) drug can be marketed freely. In making their recommendation, EC experts will not worry about safety
-
US drug firms put Third World lives at risk
Inadequate information on the labels of US drug products sold in the Third World have put many lives at risk, concludes a US government study
-
Cracking the code
THE ANGLO-US pharmaceuticals group, SmithKline Beecham, has linked up with Human Genome Services of the US to convert DNA coding data into commercial products, especially new drugs. Glaxo and Roche
-
Drug dilemma
THE JAPANESE pharmaceutical industry will shrink by 10 per cent in three years because of government plans to tighten price controls, say analysts. Drug manufacturers in Japan usually offset
-
Liquid chromatographic analysis of antibacterial drug residues in food products of animal origin
This paper reviews recent developments in the liquid chromatographic (LC) methods of analysis for the residues of antibiotics (aminoglycosides, chloramphenicol, sulfonamides, tetracyclines, macrolides, ?-lactams, etc.) in food products of animal origin.
-
Dhaka to give drug policy a free market dose
Under pressure from transnationals, the Bangladesh government is likely to ease restrictions on producing and importing medicines.
-
Malaria breakthrough promises better drugs
Now that they have discovered how chloroquine controls the malaria parasite, scientists hope to use this knowledge to develop more efficient anti malarial drugs.
-
The state of Bangladesh's health care
A visit to a Dhaka clinic provides a good idea of the extent to which drugs can help.
-
Some drugs are more essential than others
If pharmaceutical companies concentrate on manufacturing and selling essential drugs, business needs and health requirements can be met.
-
For a rational policy
Opposing the pharmaceutical sector's arguments for a more liberal drug policy, several voluntary groups demand all prescription drugs in India should be subject to price controls. The groups met in